Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein (Q44863553)

6 December 2017

title

Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein (English)

1 reference

feline immunodeficiency virus

6 December 2017

main subject

transmembrane protein

0 references

object named as

feline immunodeficiency virus

1 reference

2

Simone Giannecchini

1 reference

6 December 2017

Giulia Freer

1

1 reference

6 December 2017

Alain Tissot

3

1 reference

6 December 2017

Martin F Bachmann

4

1 reference

6 December 2017

Paolo Rovero

5

1 reference

6 December 2017

Pierre Francoise Serres

6

1 reference

6 December 2017

Mauro Bendinelli

7

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

6 December 2017

number of pages

10

1 reference

inferred from page(s)

published in

Virology

1 reference

6 December 2017

volume

322

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

360-369

1 reference

Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Structural analysis of the epitope of the anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

HIV entry and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Mutilation of RNA phage Qbeta virus-like particles: from icosahedrons to rods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

HIV-1 membrane fusion: targets of opportunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Retroinverso analogue of the antiviral octapeptide C8 inhibits feline immunodeficiency virus in serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

The Membrane-Proximal Region of Vesicular Stomatitis Virus Glycoprotein G Ectodomain Is Critical for Fusion and Virus Infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Peptide and non-peptide HIV fusion inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Recombinant RNA phage Q beta capsid particles synthesized and self-assembled in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

HIV fusion and its inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Virus-like particles as a modular system for novel vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Most potential linear B cell epitopes of Env glycoproteins of feline immunodeficiency virus are immunogenically silent in infected cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Viral fusion proteins: multiple regions contribute to membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Hepatitis B virus core particles as epitope carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Nucleotide sequence and genomic organization of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

FIV infection of the domestic cat: an animal model for AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Epitope-vaccine as a new strategy against HIV-1 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

7 January 2021

B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

7 January 2021

Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

7 January 2021

A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.02.017

7 January 2021

10.1016/J.VIROL.2004.02.017

Identifiers

DOI

1 reference

6 December 2017

1 reference